Publications SOMA.LIV

  • Symptomerleben und Coping-Strategien bei Patient*innen mit Primär Biliärer Cholangitis: eine qualitative Interviewstudie im Rahmen von SOMA.LIV
    Hasenbank N, Buck L, Maehder K, Hartl J, Löwe B, Schramm C, Toussaint A.
    Psychother Psychosom Med Psychol 2024; doi: 10.1055/a-2434-6837

    Find the publication here

    Understanding illness experiences of patients with primary sclerosing cholangitis: a qualitative analysis within the SOMA.LIV study.
    Loesken C, Maehder K, Buck L, Hartl J, Löwe B, Schramm C,Toussaint A.
    BMC GASTROENTEROL 23, 12 (2023). doi.10.1186/s12876-023-02645-2

    Find the publication here

    Factors associated with severity andpersistence of fatigue in patients withprimary biliary cholangitis: study protocolof a prospective cohort study with a mixed-methodsapproach (SOMA.LIV).
    Toussaint A, Buck L, Hartl J, Löwe B, Schramm C.
    BMJ OPEN 2022;12:e061419. doi:10.1136/bmjopen-2022-061419

    Find the publication here

  • Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.
    Löwe B, Levenson J, Depping M, Hüsing P, Kohlmann S, Lehmann M, Shedden-Mora M, Toussaint A, Uhlenbusch N, Weigel A. (2021)
    PSYCHOL MED. 1-17. doi: 10.1017/S0033291721004177. Epub ahead of print.

    Find the publication here

    Persistence rate of DSM-5 somatic symptom disorder: 4-year follow-up in patients from a psychosomatic outpatient clinic.
    Behm AC, Hüsing P, Löwe B, Toussaint A. (2021)
    COMPR PSYCHIATRY.110:152265. doi: 10.1016/j.comppsych.2021.152265.
    Epub 2021 Jul 19. PMID: 34311179.

    Find the publication here

    A disease-specific decline of the relative abundance of Bifidobacterium in patients with autoimmune hepatitis.
    Liwinski T, Casar C, Ruehlemann MC, Bang C, Sebode M, Hohenester S, Denk G, Lieb W, Lohse AW, Franke A, Schramm C.
    ALIMENT PHARMACOL THER. 2020;51(12):1417-28.

    Find the publication here

    Alterations of the bile microbiome in primary sclerosing cholangitis.
    Liwinski T, Zenouzi R, John C, Ehlken H, Rühlemann MC, Bang C, Groth S, Lieb W, Kantowski M, Andersen N, Schachschal G, Karlsen TH, Hov JR, Rösch T, Lohse AW, Heeren J, Franke A, Schramm C.
    GUT. 2020;69(4):665-72.

    Find the publication here

    Detecting DSM-5 somatic symptom disorder: criterion validity of the Patient Health Questionnaire-15 (PHQ-15) and the Somatic Symptom Scale-8 (SSS-8) in combination with the Somatic Symptom Disorder – B Criteria Scale (SSD-12).
    Toussaint A, Hüsing P, Kohlmann S, Löwe B.
    PSYCHOL MED. 2020;50(2):324-33.

    Find the publication here

    Patients With Primary Biliary Cholangitis and Fatigue Present With Depressive Symptoms and Selected Cognitive Deficits, but With Normal Attention Performance and Brain Structure.
    Zenouzi R, van der Gablentz J, Heldmann M, Göttlich M, Weiler-Normann C, Sebode M, Ehlken H, Hartl J, Fellbrich A, Siemonsen S, Schramm C, Münte TF, Lohse AW.
    PLOS ONE. 2018;13(1):e0190005.

    Find the publication here

    Bile Acids, the Microbiome, Immunity, and Liver Tumors.
    Schramm C.
    NEW ENGL J MED. 2018;379(9):888-90.

    Find the publication here

    Comparing diagnostic concepts of ICD-10 somatoform disorders and DSM-5 somatic symptom disorders in patients from a psychosomatic outpatient clinic.
    Hüsing P, Löwe B, Toussaint A.
    J PSYCHSOM RES. 2018;113:74-80.

    Find the publication here

    Core outcome domains for clinical trials on somatic symptom disorder, bodily distress disorder and functional somatic syndromes: EURONET-SOMA recommendations.
    Rief W, Burton C, Frostholm L, Henningsen P,Kleinstäuber M, Kop WJ, Löwe B, Martin A, Malt U, Rosmalen J, Schröder A, Shedden-Mora M, Toussaint A, van der Feltz-Cornelis C, EURONET-SOMA Group.
    PSYCHOSOM MED. 2017;79(9):1008-15.

    Find the publication here

    A European research network to improve diagnosis, treatment and care for patients with persistent somatic symptoms: work report of the EURONET-SOMA conference series.
    Weigel A, Hüsing P, Kohlmann S, Lehmann M, Shedden Mora M, Toussaint A, Löwe B.
    J PSYCHOSOM RES. 2017;97:136-8.

    Find the publication here

    Primary biliary `cirrhosis´: time to replace a misnomer.
    Wahl I, Feige A, Löwe B, Weiler-Normann C, Rose MD, Lohse AW, Schramm C.
    HEPATOLOGY. 2015;61(3):1091.

    Find the publication here

    Health-related quality of life, depression, and anxiety in patients with autoimmune hepatitis.
    Schramm C, Wahl I, Weiler-Normann C, Voigt K, Wiegard C, Glaubke C, Brähler E, Löwe B, Lohse AW, Rose M.
    J HEPATOL. 2014;60(3):618-24.

    Find the publication here

  • Krankheitserfahrungen von Patient:innen mit primär sklerosierender Cholangitis
    - eine qualitative Analyse im Rahmen der SOMA.LIV Studie
    Lösken C.
    German Congress for Psychosomatic Medicine and Psychotherapy, 3.-5. May 2023, Berlin, Germany. [Lecure, 5. May 2023]

    Der Einfluss von Symptomerwartungen auf mentale Fatigue bei Patient:innen mit Primär Biliärer Cholangitis (SOMA.LIV)
    Buck L.
    German Congress for Psychosomatic Medicine and Psychotherapy, 3.-5. May 2023, Berlin, Germany. [Lecure, 4. May 2023]

    Symptomwahrnehmung bei Patient:innen mit Primär Biliärer Cholangitis (SOMA.LIV)
    Hasenbank N.
    German Congress for Psychosomatic Medicine and Psychotherapy, 3.-5. May 2023, Berlin, Germany. [Lecure, 4. May 2023]